Some early reports suggest a recovery is unlikely in 2025. In January, Tesla's sales plunged by over 50% year over year ...
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...
While facing near-term volume pressures, management says Old Dominion's sustained investment in network capacity and ...
Palantir Technologies Stock Is Down More Than 25% Since Its Peak. Is It Finally Time to Buy the Dip?
For a while, it seemed Palantir Technologies ( PLTR -9.68%) could do no wrong, with the stock gaining as much as 1,250% the ...
The only year in which the S&P 500 performed better was 2022, when it lost 20.4% and the Magnificent Seven lost 41.3%. That ...
Shares of Alibaba ( BABA -9.10%) were taking a dive today after investors balked at the company's big spending plans in cloud ...
Nike's stock cratered 55% from its highs after the company alienated many of its product distribution partners over the last ...
Database company MongoDB ( MDB -2.76%) tumbled 3% through 12:30 p.m. ET Monday after Bernstein analyst Firoz Valliji cut his ...
Yet SoundHound remains a small company pursuing a potentially massive niche, so if things go well, its stock could deliver ...
Oil stocks can be excellent sources of passive income for investors who can stomach the volatility of the cyclical energy ...
Lucid is still struggling to scale up its business, but it had $5.16 billion in liquidity at the end of the third quarter of ...
Medtronic ( MDT 2.27%) and Johnson & Johnson ( JNJ 1.64%) are two very healthy, high-yielding dividend stocks. This makes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results